ROIV ▲ +5.6% - Roivant Sciences Ltd.
$ROIV reported Q2 2027 EPS of -$0.27, beating the -$0.46 estimate by 41.3%. Revenue of $35.1M beat the $3.8M estimate by 822.5%.
09-NOV-2026 07:09 AM ET
Share this post
More filings for $ROIV
ROIV ▲ +4.0% - Roivant Sciences Ltd.Nov 9, 2026ROIV - Roivant Sciences Ltd. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ROIV ▼ -0.2% - Roivant Sciences Ltd.Oct 29, 2026ROIV - Roivant Sciences Ltd. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026ROIV ▲ +6.2% - Roivant Sciences Ltd.Oct 21, 2026ROIV ▲ +4.7% - Roivant Sciences Ltd.Oct 21, 2026
View full $ROIV filing history →💬 Comments
Loading comments…
Leave a comment